CEL-SCI Corporation (CVM, Financial) has unveiled the pricing details for a best-efforts offering involving 1.5 million shares of its common stock. Each share is being sold at $3.82, aligning with at-the-market pricing rules under NYSE American regulations. The offering is anticipated to yield approximately $5.7 million in gross proceeds prior to the deduction of placement agent fees and other expenses.
The closing of this transaction is scheduled for July 14, subject to standard closing conditions. The funds raised will support the ongoing development of Multikine, alongside covering general corporate expenses and providing working capital. ThinkEquity has been appointed as the sole placement agent for this offering.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for CEL-SCI Corp (CVM, Financial) is $300.00 with a high estimate of $300.00 and a low estimate of $300.00. The average target implies an upside of 5,805.40% from the current price of $5.08. More detailed estimate data can be found on the CEL-SCI Corp (CVM) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, CEL-SCI Corp's (CVM, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
